oleic acid has been researched along with candesartan cilexetil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ahmad, FJ; Ali, A; Fazil, M; Hafeez, A; Imam, SS; Khan, S; Paudel, A | 1 |
| AbuElfadl, A; Boughdady, M; Meshali, M | 1 |
3 other study(ies) available for oleic acid and candesartan cilexetil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Benzimidazoles; Biological Availability; Biphenyl Compounds; Blood Pressure; Drug Carriers; Drug Liberation; Drug Stability; Female; Glycerides; Intestinal Absorption; Male; Nanoparticles; Oleic Acid; Particle Size; Rats, Wistar; Tetrazoles | 2017 |
New Peceol™/Span™ 60 Niosomes Coated with Chitosan for Candesartan Cilexetil: Perspective Increase in Absolute Bioavailability in Rats.
Topics: Administration, Oral; Animals; Benzimidazoles; Biological Availability; Biphenyl Compounds; Caco-2 Cells; Chitosan; Glycerol; Humans; Liposomes; Oleic Acid; Rats; Tetrazoles | 2021 |